Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
8 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Single-center technical validation of a novel segmentation architecture on a held-out cohort, comparing computational efficiency and performance metrics without independent test set or clinical outcome evaluation.
A theoretical protocol with convergence analysis and experimental validation on standard datasets, but without clinical or real-world deployment evidence, peer review, or comparison to deployed federated learning systems.
This is an unpeer-reviewed arXiv preprint describing a machine learning framework for LLM tool-calling; it has not undergone peer review and reports only computational benchmarks without clinical or human validation.
This is an early-stage machine learning method paper presenting a novel framework without peer review, demonstrating proof-of-concept across benchmarks but lacking independent validation or clinical applicability.
Preclinical proof-of-concept study in cell culture and animal models demonstrating a novel composite material's ability to modulate the tumor microenvironment and enhance immune engagement; no human data or clinical endpoints reported.
This is a protocol for a planned systematic review and network meta-analysis, not a completed study with empirical results; it describes the design and methods that will be used to evaluate PEI and CBT but reports no data or findings.
A bibliometric analysis mapping research trends and gaps in UC-depression comorbidity; useful for research direction but not clinical evidence on intervention efficacy or harm.
A narrative review synthesizing current knowledge on T. phagedenis biology, pathogenesis, immunity, and control in bovine digital dermatitis, offering expert recommendations for future research and control strategies.